These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 17003471
1. Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction. Kamijo-Ikemori A, Sugaya T, Obama A, Hiroi J, Miura H, Watanabe M, Kumai T, Ohtani-Kaneko R, Hirata K, Kimura K. Am J Pathol; 2006 Oct; 169(4):1107-17. PubMed ID: 17003471 [Abstract] [Full Text] [Related]
3. Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury. Ichikawa D, Kamijo-Ikemori A, Sugaya T, Shibagaki Y, Yasuda T, Hoshino S, Katayama K, Igarashi-Migitaka J, Hirata K, Kimura K. Am J Physiol Renal Physiol; 2015 Jan 15; 308(2):F114-21. PubMed ID: 25339700 [Abstract] [Full Text] [Related]
4. Renal liver-type fatty acid binding protein attenuates angiotensin II-induced renal injury. Ichikawa D, Kamijo-Ikemori A, Sugaya T, Yasuda T, Hoshino S, Igarashi-Migitaka J, Hirata K, Kimura K. Hypertension; 2012 Oct 15; 60(4):973-80. PubMed ID: 22926951 [Abstract] [Full Text] [Related]
5. Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy. Zuo N, Suzuki Y, Sugaya T, Osaki K, Kanaguchi Y, Wang L, Tomino Y. Nephrol Dial Transplant; 2011 Jul 15; 26(7):2127-37. PubMed ID: 21109611 [Abstract] [Full Text] [Related]
7. Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity. Matsui K, Kamijo-Ikemorif A, Sugaya T, Yasuda T, Kimura K. Am J Pathol; 2011 Mar 15; 178(3):1021-32. PubMed ID: 21356355 [Abstract] [Full Text] [Related]
8. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Kamijo A, Sugaya T, Hikawa A, Okada M, Okumura F, Yamanouchi M, Honda A, Okabe M, Fujino T, Hirata Y, Omata M, Kaneko R, Fujii H, Fukamizu A, Kimura K. Am J Pathol; 2004 Oct 15; 165(4):1243-55. PubMed ID: 15466390 [Abstract] [Full Text] [Related]
9. Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice. Kamijo-Ikemori A, Sugaya T, Matsui K, Yokoyama T, Kimura K. Nephrology (Carlton); 2011 Aug 15; 16(6):539-44. PubMed ID: 21504508 [Abstract] [Full Text] [Related]
10. Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis. Kanaguchi Y, Suzuki Y, Osaki K, Sugaya T, Horikoshi S, Tomino Y. Nephrol Dial Transplant; 2011 Nov 15; 26(11):3465-73. PubMed ID: 21525165 [Abstract] [Full Text] [Related]
11. Renoprotective effect of renal liver-type fatty acid binding protein and angiotensin II type 1a receptor loss in renal injury caused by RAS activation. Ichikawa D, Kamijo-Ikemori A, Sugaya T, Shibagaki Y, Yasuda T, Katayama K, Hoshino S, Igarashi-Migitaka J, Hirata K, Kimura K. Am J Physiol Renal Physiol; 2014 Mar 15; 306(6):F655-63. PubMed ID: 24431207 [Abstract] [Full Text] [Related]
12. Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Sunami R, Sugiyama H, Wang DH, Kobayashi M, Maeshima Y, Yamasaki Y, Masuoka N, Ogawa N, Kira S, Makino H. Am J Physiol Renal Physiol; 2004 Jun 15; 286(6):F1030-8. PubMed ID: 14722014 [Abstract] [Full Text] [Related]
13. Role of the high-affinity leukotriene B4 receptor signaling in fibrosis after unilateral ureteral obstruction in mice. Kamata M, Amano H, Ito Y, Fujita T, Otaka F, Hosono K, Kamata K, Takeuchi Y, Yokomizo T, Shimizu T, Majima M. PLoS One; 2019 Jun 15; 14(2):e0202842. PubMed ID: 30818366 [Abstract] [Full Text] [Related]
14. The role of purinergic P2X7 receptors in the inflammation and fibrosis of unilateral ureteral obstruction in mice. Gonçalves RG, Gabrich L, Rosário A, Takiya CM, Ferreira ML, Chiarini LB, Persechini PM, Coutinho-Silva R, Leite M. Kidney Int; 2006 Nov 15; 70(9):1599-606. PubMed ID: 16969386 [Abstract] [Full Text] [Related]
15. Attenuation of ureteral obstruction-induced renal injury by polyenylphosphatidylcholine. Akin M, Demirbilek S, Ay S, Gurunluoglu K, Turkmen E, Tas E, Aksoy RT, Baykarabulut A, Edali MN. Int J Urol; 2007 Apr 15; 14(4):350-6. PubMed ID: 17470170 [Abstract] [Full Text] [Related]
16. Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-beta. Wright EJ, McCaffrey TA, Robertson AP, Vaughan ED, Felsen D. Lab Invest; 1996 Feb 15; 74(2):528-37. PubMed ID: 8780170 [Abstract] [Full Text] [Related]
17. Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Sugiyama H, Kobayashi M, Wang DH, Sunami R, Maeshima Y, Yamasaki Y, Masuoka N, Kira S, Makino H. Nephrol Dial Transplant; 2005 Dec 15; 20(12):2670-80. PubMed ID: 16141465 [Abstract] [Full Text] [Related]
18. Renal functional decline and glomerulotubular injury are arrested but not restored by release of unilateral ureteral obstruction (UUO). Chaabane W, Praddaude F, Buleon M, Jaafar A, Vallet M, Rischmann P, Galarreta CI, Chevalier RL, Tack I. Am J Physiol Renal Physiol; 2013 Feb 15; 304(4):F432-9. PubMed ID: 23220725 [Abstract] [Full Text] [Related]
19. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Vieira JM, Mantovani E, Rodrigues LT, Dellê H, Noronha IL, Fujihara CK, Zatz R. Nephrol Dial Transplant; 2005 Aug 15; 20(8):1582-91. PubMed ID: 15855201 [Abstract] [Full Text] [Related]
20. Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury. Negishi K, Noiri E, Maeda R, Portilla D, Sugaya T, Fujita T. Kidney Int; 2008 Jun 15; 73(12):1374-84. PubMed ID: 18368030 [Abstract] [Full Text] [Related] Page: [Next] [New Search]